154 related articles for article (PubMed ID: 6436227)
1. The relative merits and drawbacks of new nucleoside analogues with clinical potential.
Oberg B; Johansson NG
J Antimicrob Chemother; 1984 Aug; 14 Suppl A():5-26. PubMed ID: 6436227
[TBL] [Abstract][Full Text] [Related]
2. Treatment of mucocutaneous herpes simplex infections.
Seidlin M; Straus SE
Clin Dermatol; 1984; 2(2):100-16. PubMed ID: 6085870
[No Abstract] [Full Text] [Related]
3. Antiherpes drugs: promises and pitfalls.
de Clercq E
Eur J Clin Microbiol; 1984 Apr; 3(2):96-107. PubMed ID: 6327297
[TBL] [Abstract][Full Text] [Related]
4. [Antiherpetics and their indications].
Goudsmit J; van der Noordaa J
Ned Tijdschr Geneeskd; 1983 Apr; 127(14):597-602. PubMed ID: 6304541
[No Abstract] [Full Text] [Related]
5. [Antiherpetic therapy].
Dediulescu L; Dediulescu DF
Oftalmologia; 2005; 49(1):72-7. PubMed ID: 15934343
[TBL] [Abstract][Full Text] [Related]
6. Antiviral chemotherapy.
White DO
Med J Aust; 1984 Jun; 140(12):715-20. PubMed ID: 6203021
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside analogues as antiviral agents.
de Clercq E
Acta Microbiol Acad Sci Hung; 1981; 28(3):289-306. PubMed ID: 6272552
[No Abstract] [Full Text] [Related]
8. [Antiviral drugs].
Coquin Y
Rev Prat; 1985 Oct; 35(47):2867-71. PubMed ID: 3937215
[No Abstract] [Full Text] [Related]
9. Ocular antiviral therapy in perspective.
Kaufman HE
J Infect Dis; 1976 Jun; 133 Suppl():A96-100. PubMed ID: 819600
[TBL] [Abstract][Full Text] [Related]
10. Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases.
Sundmacher R
Metab Pediatr Syst Ophthalmol; 1983; 7(2):89-94. PubMed ID: 6686278
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy of herpetic infections].
Barinskiĭ IF; L'vov ND; Samoĭlovich EO
Vopr Virusol; 1986; 31(1):6-18. PubMed ID: 3515765
[No Abstract] [Full Text] [Related]
12. Diagnosis and management of viral infections.
Turner PA; Rytel MW
Compr Ther; 1984 Jun; 10(6):20-9. PubMed ID: 6203680
[TBL] [Abstract][Full Text] [Related]
13. Rational design of arabinosyl nucleosides as antitumor and antiviral agents.
Müller WE
Jpn J Antibiot; 1977 Dec; 30 Suppl():104-20. PubMed ID: 612702
[TBL] [Abstract][Full Text] [Related]
14. Physical and biological consequences of incorporation of antiviral agents into virus DNA.
Prusoff WH; Mancini WR; Lin TS; Lee JJ; Siegel SA; Otto MJ
Antiviral Res; 1984 Dec; 4(6):303-15. PubMed ID: 6099709
[TBL] [Abstract][Full Text] [Related]
15. Antiviral agents.
Lefrock JL; Smith BR
Am Fam Physician; 1983 Jan; 27(1):237-40. PubMed ID: 6297287
[No Abstract] [Full Text] [Related]
16. Advances in antiviral chemotherapy.
King DH
J Am Vet Med Assoc; 1984 Nov; 185(10):1115-7. PubMed ID: 6096322
[No Abstract] [Full Text] [Related]
17. In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine.
Nasisse MP; Guy JS; Davidson MG; Sussman W; De Clercq E
Am J Vet Res; 1989 Jan; 50(1):158-60. PubMed ID: 2493210
[TBL] [Abstract][Full Text] [Related]
18. [Antiviral treatment].
Hermans P
Acta Urol Belg; 1993; 61(1-2):593-8. PubMed ID: 7685982
[No Abstract] [Full Text] [Related]
19. Biochemical aspects of the selective antiherpes activity of nucleoside analogues.
De Clercq E
Biochem Pharmacol; 1984 Jul; 33(14):2159-69. PubMed ID: 6147138
[No Abstract] [Full Text] [Related]
20. Therapy of viral infections.
Grieco MH
Bull N Y Acad Med; 1982 Nov; 58(8):711-20. PubMed ID: 6301589
[No Abstract] [Full Text] [Related]
[Next] [New Search]
